Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/2000
06/02/2000CA2352083A1 Zace1: a human metalloenzyme
06/02/2000CA2351885A1 Test kit and method of diagnosing severe acute pancreatitis
06/02/2000CA2351880A1 Dna molecules encoding hg51, a g-protein-coupled receptor
06/02/2000CA2351736A1 Methods of identifying antigen gene sequences
06/02/2000CA2351567A1 Mutation of the parkin gene, compositions, methods and uses
06/02/2000CA2351365A1 Potassium channel interactors and uses therefor
06/02/2000CA2351361A1 Gtpase associated proteins
06/02/2000CA2351311A1 Uses for eph receptor antagonists and agonists to treat vascular disorders
06/02/2000CA2350405A1 Method of using pon-1 to decrease atheroma formation
06/02/2000CA2349290A1 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
06/02/2000CA2347850A1 Regulatory protein pke#83 from human keratinocytes
06/02/2000CA2347700A1 Antibodies to peptides that target git receptors and related methods
06/01/2000CA2252965A1 Novel suppressor of fused (sufu) gene
05/2000
05/31/2000EP1004670A2 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
05/31/2000EP1004668A2 Regulatory protein pKe 83 derived from human keratinocytes
05/31/2000EP1004666A1 Protein having pdz domain sequence
05/31/2000EP1004665A1 Scavenger receptor-like proteins
05/31/2000EP1004598A2 Coated carrier materials for the purification of blood, plasma and tissues, and columns comprising said carrier materials
05/31/2000EP1004323A1 Method for producing immunoglobulin preparations
05/31/2000EP1004315A1 Preventives and/or remedies for systemic lupus erythematosus containing anti-il-6 receptor antibody as the active ingredient
05/31/2000EP1004313A1 Cachexia remedy
05/31/2000EP1004312A1 Method for treating multiple sclerosis
05/31/2000EP1004299A1 Antigen inducers, vaccine precursors, vaccines, antibodies, neutralizing antibodies, antitoxins, idiotypic antibodies, and anti-idiotypic antibodies induced by the idiotypic antibodies
05/31/2000EP1003889A1 NOVEL $i(PICHIA PASTORIS) GENE SEQUENCES AND METHODS FOR THEIR USE
05/31/2000EP1003888A2 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
05/31/2000EP1003880A2 Human ubiquitin carrier protein e2-like protein and cyclin b-like protein
05/31/2000EP1003878A2 Hiv-1 group o antigens and uses thereof
05/31/2000EP1003877A2 Papilloma virus, agents for the detection thereof and for the therapy of the diseases caused by said virus
05/31/2000EP1003874A1 Neisseria lactoferrin binding protein
05/31/2000EP1003866A1 Method for identifying and locating expressed epil peptides, coded by the insl4 gene and their uses
05/31/2000EP1003864A1 Trail receptors, nucleic acids encoding the same, and methods of use thereof
05/31/2000EP1003863A1 Mammalian cytokine receptor-11
05/31/2000EP1003862A1 Human longevity-assurance protein homologs
05/31/2000EP1003861A2 Mammalian cell membrane proteins; related reagents
05/31/2000EP1003858A1 New human growth regulator protein
05/31/2000EP1003856A1 Apaf-1, the ced-4 human homolog, an activator of caspase-3
05/31/2000EP1003853A1 Methods for protein screening
05/31/2000EP1003851A2 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy
05/31/2000EP1003842A1 Catalytic monoclonal antibodies for the in vivo transformation of corticosteroid prodrugs
05/31/2000EP1003841A1 Establishment of hhv-8+ lymphoma cell line, virus produced, antibody, diagnostic method and kit for detecting hhv-8 infection
05/31/2000EP1003787A2 Agent for the treatment and/or prophylaxis of microcirculation disorders
05/31/2000EP1003783A2 Lipoprotein-regulating medicaments
05/31/2000EP1003782A1 Ligand for herpes simplex virus entry mediator and methods of use
05/31/2000EP1003781A1 Interleukin-18 binding proteins, their preparation and use
05/31/2000EP1003780A1 Human f11 antigen: a cell surface receptor involved in platelet aggregation
05/31/2000EP1003779A1 Reagents and methods useful for detecting diseases of the breast
05/31/2000EP1003778A1 Isolated osteocalcin fragments
05/31/2000EP1003777A1 PGC-1, A NOVEL BROWN FAT PPAR$g(g) COACTIVATOR
05/31/2000EP1003773A1 Ctl epitopes from ebv
05/31/2000EP1003767A1 Human tumor necrosis factor receptor tr10
05/31/2000EP1003766A1 Tumor surface protein and its complementary surface receptor on naive natural killer cells
05/31/2000EP1003763A1 83 human secreted proteins
05/31/2000EP1003552A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION
05/31/2000EP1003547A1 Agonist murine monoclonal antibody as a stimulant for megakaryocytopoiesis
05/31/2000EP1003545A1 Heparin-binding growth factor (hbgf) polypeptides
05/31/2000EP1003540A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
05/31/2000EP1003379A1 Novel phytase
05/31/2000EP1003363A1 HYPERSENSITIVE RESPONSE ELICITOR FROM $i(ERWINIA AMYLOVORA), ITS USE, AND ENCODING GENE
05/31/2000EP0939651B1 Materials and methods relating to the diagnosis and treatment of pre-eclampsia
05/31/2000EP0804559A4 Enzyme for cleavage of the anchor region of surface proteins from gram positive bacteria
05/31/2000EP0635016B1 Benzodiazepine derivatives and protein and polypeptide conjugates thereof
05/31/2000EP0584082B1 Domains of extracellular region of human platelet derived growth factor receptor polypeptides
05/31/2000CN1255166A Method for integrating genes at specific sites in mammalian cells via homologous recombination and used carrier
05/31/2000CN1255163A Compounds
05/31/2000CN1254756A Attenuated virus of ox's viral diarrhea
05/31/2000CN1254717A Immunotoxin
05/30/2000US6069301 Antibodies which bind to insect gut proteins and their use
05/30/2000US6069242 Mixture of pharmaceutically acceptable carrier and antisense nucleic acid; for diagnosis, imaging, anticarcinogenic agents, antitumor agents
05/30/2000US6069239 Expression system present in compatible host cell which produces a ligand regulated transcription factor; antiinflammatory/antiarthritic/antidiabetic agents; treatment of autoimmune diseases; diagnosis of related diseases
05/30/2000US6069236 Desalting, chromatography on anion exchange gel, viral deactivation using solvent-detergent treatment, chromatography on cation exchange gel, recovering; does not cause aggregate-induced complement activation
05/30/2000US6069231 Amino acid sequences of domains found in transcription factors including a mammalian retinoblastoma-interacting zinc finger protein; for fusion proteins useful for regulating transcription of target genes; diagnosis of related diseases
05/30/2000US6069230 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications
05/30/2000US6069127 Human infant formula containing a glycoprotein specific for binding to the human mac-2 (macrophage antigen) lectin; to prevent infections
05/30/2000US6068986 Antibodies specific for d-myo-inositol 1,4,5-trisphosphate and the enzyme-linked immunosorbent assay of d-myo-inositol 1,4,5-trisphosphate
05/30/2000US6068984 Separating hb15 prositive cells from population of unrelated cells by reacting antibody that specifically binds the extracellular, transmembrane or cytoplasmic domain of the glycoprotein, then isolating cells
05/30/2000US6068982 Ubiquitin conjugating enzymes
05/30/2000US6068842 A polypeptide containing 66 kda protein of borrelia afzelli
05/30/2000US6068841 Antibodies to Fas-L for treatment of hepatitis
05/30/2000US6068840 Recombinant CDR-grafted and chimeric anti-IL-8 antibodies containing CDRs or the variable region from the mouse monoclonal antibody, WS-4
05/30/2000US6068838 Purified multimerase having proteolytic activity, converts von willebrand factor having a singlet structure to von willebrand factor having satellite structure and is active in presence of serine protease and calpin protease inhibitor
05/30/2000CA2676762A1 Peptides for the detection of hiv-1 group o
05/30/2000CA2119128C Alleviation of symptoms associated with inflammatory disease states
05/30/2000CA2045200C Immobilization of biomolecules by enhanced electophoretic precipitation
05/26/2000CA2252967A1 Protein fragments for use in protein targeting
05/25/2000WO2000029850A1 An immunoassay for the determination of transmissible spongiform encephalopathies in bovine
05/25/2000WO2000029849A1 An immunoassay for the determination of transmissible spongiform encephalopathies in mammals
05/25/2000WO2000029623A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
05/25/2000WO2000029620A1 Methods of facilitating vascular growth
05/25/2000WO2000029596A1 Phosphonate metabolizing plants
05/25/2000WO2000029584A1 Antibody variants with higher binding affinity compared to parent antibodies
05/25/2000WO2000029583A2 Immunoglobulin superfamily proteins
05/25/2000WO2000029581A1 Human tslp dna and polypeptides
05/25/2000WO2000029580A1 Calcium binding protein
05/25/2000WO2000029579A1 Mammalian chondromodulin-like protein
05/25/2000WO2000029578A1 Cloning and characterization of two m-rna transcription factors
05/25/2000WO2000029577A1 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof
05/25/2000WO2000029574A2 Inflammation-associated genes
05/25/2000WO2000029572A1 Proteins maguin
05/25/2000WO2000029569A1 Methods of diagnosing or treating neurological diseases
05/25/2000WO2000029564A2 Human glycine transporter type 2